Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the efficacy and safety of KPI-121
ophthalmic suspension compared to placebo in subjects who have undergone cataract surgery.
The efficacy and safety of two different concentrations and two different dosing regimens of
KPI-121 are also being assessed.